Skip to main content
    Back to episode
    Episode 28 · April 2, 2026 · 35m listen · 5,719 words · ~29 min read

    Start QMS Early to Avoid Reverse Documentation with Dr. Basant Bajpai | Ep. 64 - Full Transcript | The Med Device Cyber Podcast

    Read the complete, searchable transcript of Episode 28 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.

    Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.

    Episode summary

    In this episode of the Med Device Cyber Podcast, host Trevor Slattery is joined by special guest Dr. Basant Bajpai, the CEO of Compliance MedQRA, a regulatory consulting firm based in Dubai that also offers an automated Quality Management System (QMS). Dr. Bajpai, who holds a PhD in neuromonitoring and neurosciences, discusses the critical importance of a properly implemented QMS for MedTech companies, particularly for startups and those in the early stages of development. He identifies a major pitfall in the industry: companies often either delay implementing a QMS or opt for overly complex, expensive systems when a simple, scalable, and traceable solution would be more effective. This mistake frequently leads to audit failures, as companies are unable to retroactively prove the traceability of their development and design processes. The core argument presented by Dr. Bajpai is the necessity of integrating a QMS from the very beginning of the product lifecycle, starting at the concept and R&D stages. He explains that while manual systems like shared drives might seem sufficient initially, they quickly become unmanageable and unscalable, resulting in significant time and financial costs to reverse-document everything for regulatory submissions. By establishing a solid, traceable foundation early on, companies can scale their operations smoothly. The conversation also explores the role of Artificial Intelligence (AI) in this space. Both speakers agree that AI is a powerful tool for assisting and improving efficiency, such as drafting documentation and flagging compliance gaps. However, they strongly caution against letting AI take full ownership. The principle of a "human in the loop" is stressed as essential for validating AI-generated content, ensuring accuracy, and maintaining ultimate responsibility, especially for critical functions like traceability, which Dr. Bajpai advises should remain a manual process to avoid potential disasters. The discussion highlights that a well-structured QMS is not just a regulatory hurdle but a fundamental business system for survival and success in the highly regulated MedTech industry. The importance of integrating cybersecurity considerations early, in parallel with the QMS, is also underscored as a key factor in preventing regulatory pushback and ensuring a smoother path to market.

    Key takeaways from this episode

    • The biggest mistake MedTech companies make is choosing overly complex, 'fancy' QMS tools instead of simple, traceable systems that fit their regulatory journey.
    • Implementing a Quality Management System (QMS) should begin as early as possible, ideally at the concept or R&D stage, to build a solid, scalable foundation.
    • Failing to establish and prove traceability is a primary reason why many companies fail regulatory audits, often due to a late or poorly managed QMS implementation.
    • Simple systems like shared drives are not scalable for a growing MedTech company and often lead to costly, time-consuming efforts to reverse-document processes later on.
    • Artificial Intelligence (AI) should be used as a tool to assist and improve the efficiency of compliance tasks, not to replace human oversight and take ownership of the process.
    • A 'human in the loop' is crucial when using AI for regulatory compliance to validate information, ensure accuracy, and maintain accountability.
    • Start with a simple, foundational QMS that meets your immediate needs; it's easier and more effective to scale a solid foundation than to fix a complex or broken system later.
    • Both regulatory compliance and cybersecurity must be integrated early into the product development lifecycle to avoid significant delays and rejections during submission.

    Full episode transcript

    Page 1 of 7· Paragraphs 1 - 8
    Basant: The biggest mistake the MedTech companies does today while they implement their QMS tool, they usually look for a product that is more of a heavy or fancy tool, while what they need is simple tool that is more traceable and that can actually fit their regulatory journey. But the challenge hit when they go for the audit and they fail in the audit because they fail to prove that what they have done is traceable. So I always recommend them, start as early as possible. You do not need fancy systems. What you need is a simple automated system which can suffice your need, which actually can help you build your foundation. And once you build the foundation is easy to scale. What we always recommend, do not use the AI until you fully establish implemented your QMS. Trevor: We don't wanna let AI take ownership over this process. We want to use it as a tool to assist and guide us throughout this process. And I think as long as we're doing that, it's an incredibly effective and incredibly powerful tool. Welcome back to the MedDevice Cyber Podcast. I'm your host Trevor Slattery. Unfortunately, our other co-host, Christian Espinosa isn't able to make it today. He's currently flying back from Seoul after a whole gambit of travel delays. But we are joined here today by a very special guest, Dr. Basant who's coming in from Dubai with Compliance MedQRA. I'd love to hear a little bit about yourself, some of your background, and what you're working on over there. Basant: Hi Trevor. Thank you. Uh, thank you for having me. My name is Dr. Basant. I'm the CEO at Compliance MedQRA. We are located in Dubai. I have a background within, uh, medical devices and I have a PhD within neuro monitoring and neuroscience. We are a regulatory consulting company. We also have an automated quality management system. Well, within MedTech industry, we believe that, uh, the QMS is not just a software, but it's a business system for survival. So having said that, in the current trend of MedTech, uh, services or within within ISO 13485, uh, the tool that that requires for quality management system is not just a tool. It requires for maintaining the traceability, to maintain the the documentation as well as the compliance, which is becoming day, uh, day by day more and more challenging for the medical device companies. The biggest mistake the MedTech companies does today while they implement their QMS tool, they usually look for a product that is more of a heavy or fancy tool, while what they need is simple tool that is more traceable and that can actually fit their regulatory journey. And that's a challenge. What happens, this, normally when we, when we communicate with, with multiple MedTech founders or CEO at early stage, they always ask when they should implement a quality management system. And that's one of the challenge that, that many of the founders that come across at the early stage when they are in the beginning. So, what they have to do, what always what we advise them, that you need to, to start as early as possible, meaning that when they are at concept stage or at the R&D stage, they have to start there because regardless, if they don't start, the design control already does start. So, they have to document that and they have to do that in the control, version controlled manner as well as traceable manner. So, that is something, uh, challenging, especially among the startup and early stage companies. And many of the companies, for example, when they opt for a system, or some of them even go a share drive or Google drive when they, when they use for the implementing the quality management system, but the challenge hit when they go for the audit and they fail in the audit because they fail to prove that what they have done is traceable and there is a sufficient audit trail. The, the documentation is, is done correctly. The different processes has been implemented and those are traceable and documented and according to the different regulatory requirements. But some of the companies are still able to make it by doing excel sheet and doing the documentation, manual work, by hiring multiple people, but that hits them hard when they scale because when they have multiple products, when they have, when they have multiple processes, records, work instructions, that then it hits hard. So I always recommend them, start as early as possible. You do not need fancy systems. What you need is a simple automated system which can suffice your need, which actually can help you build your foundation, and once you build the foundation, is easy to scale. So from day one, if you're a startup, if you, if you're looking for a complex quality management system, you might not have resource to implement it and you might not able to actually accommodate all the processes and black box and processes that are already designed by these QMS providers.
    1 / 7